MFS
ECYT

MSI Financial Services’s Endocyte, Inc. Common Stock ECYT Stock Holding History

MSI Financial Services’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Hold
100
– – ﹤0.01% 4124
2016
Q3 		$0 Sell
100
-100
-50% -$312 ﹤0.01% 4141
2016
Q2 		$1K Hold
200
– – ﹤0.01% 3836
2016
Q1 		$1K Hold
200
– – ﹤0.01% 3860
2015
Q4 		$1K Buy
+200
New +$921 ﹤0.01% 3756

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MSI Financial Services's ECYT Position: Q4 2016 in Review

MSI Financial Services held its Endocyte, Inc. Common Stock (ECYT) position steady in Q4 2016 at 100 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4124.

MSI Financial Services first reported a position in ECYT in Q4 2015 and has held it in 5 quarters since. The position peaked at $1K in Q2 2016. 96 funds tracked by Wall St. Rank hold ECYT as of Q4 2016.

  • MSI Financial Services held 100 shares of Endocyte, Inc. Common Stock worth $0 as of Q4 2016.
  • MSI Financial Services left its Endocyte, Inc. Common Stock share count unchanged in Q4 2016.
  • Endocyte, Inc. Common Stock made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #4124 holding.
  • MSI Financial Services first reported a position in Endocyte, Inc. Common Stock in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's Endocyte, Inc. Common Stock position peaked at $1K in Q2 2016.
  • 96 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.